1,2,3-Trichloropropane multiple interactions ISO RGD:730900 6480464 1 more ... CTD PMID:22952646 1,2-dimethylhydrazine decreases expression ISO RGD:11134 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPP3CA mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:730900 6480464 Dinitrochlorobenzene binds to PPP3CA protein CTD PMID:32991956 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPP3CA mRNA CTD PMID:20068009 17beta-estradiol decreases expression ISO RGD:730900 6480464 Estradiol results in decreased expression of PPP3CA mRNA CTD PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP3CA mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PPP3CA mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11134 6480464 Tetrachlorodibenzodioxin affects the expression of PPP3CA mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PPP3CA mRNA CTD PMID:21346803 2-deoxy-D-glucose decreases response to substance ISO RGD:11134 6480464 PPP3CA protein results in decreased susceptibility to Deoxyglucose CTD PMID:10679475 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PPP3CA mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:730900 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPP3CA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PPP3CA mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of PPP3CA mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:11134 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PPP3CA mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:730900 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPP3CA mRNA CTD PMID:28628672 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of PPP3CA mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression ISO RGD:730900 6480464 4-hydroxy-2-nonenal results in decreased expression of PPP3CA mRNA CTD PMID:12419474 5-fluorouracil multiple interactions ISO RGD:730900 6480464 [Fluorouracil co-treated with irinotecan] results in increased expression of PPP3CA mRNA, PPP3CA protein affects the susceptibility to [Fluorouracil co-treated with irinotecan analog] CTD PMID:16391804 , PMID:18927307 5-fluorouracil increases expression ISO RGD:730900 6480464 Fluorouracil results in increased expression of PPP3CA protein CTD PMID:15585135 , PMID:16803524 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PPP3CA mRNA CTD PMID:24780913 , PMID:25825206 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PPP3CA mRNA CTD PMID:31881176 acetazolamide increases expression ISO RGD:11134 6480464 Acetazolamide results in increased expression of PPP3CA mRNA CTD PMID:19274763 acetylleucyl-leucyl-norleucinal multiple interactions ISO RGD:11134 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Acetaminophen results in increased cleavage of PPP3CA protein] CTD PMID:35713544 acrolein multiple interactions ISO RGD:730900 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPP3CA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPP3CA mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO RGD:11134 6480464 Aflatoxin B1 results in decreased expression of PPP3CA mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:730900 6480464 Aflatoxin B1 results in decreased methylation of PPP3CA gene, Aflatoxin B1 results in decreased methylation of PPP3CA intron CTD PMID:27153756 , PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:730900 6480464 Tretinoin results in decreased expression of PPP3CA mRNA CTD PMID:16140955 , PMID:21934132 alpha-pinene multiple interactions ISO RGD:730900 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPP3CA mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPP3CA mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP3CA mRNA CTD PMID:16483693 arecoline increases expression EXP 6480464 Arecoline results in increased expression of PPP3CA protein CTD PMID:34999050 aristolochic acid A decreases expression ISO RGD:730900 6480464 aristolochic acid I results in decreased expression of PPP3CA mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:11134 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of PPP3CA mRNA CTD PMID:23650126 arsenous acid increases expression ISO RGD:730900 6480464 Arsenic Trioxide results in increased expression of PPP3CA mRNA CTD PMID:17963750 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPP3CA mRNA CTD PMID:29223816 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of PPP3CA mRNA CTD PMID:27377005 benzatropine increases expression ISO RGD:730900 6480464 Benztropine results in increased expression of PPP3CA protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:11134 6480464 Benzo(a)pyrene results in decreased expression of PPP3CA mRNA CTD PMID:20504355 , PMID:21715664 benzo[a]pyrene increases methylation ISO RGD:11134 6480464 Benzo(a)pyrene results in increased methylation of PPP3CA intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:730900 6480464 Benzo(a)pyrene results in decreased expression of PPP3CA mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:730900 6480464 7 more ... CTD PMID:19150397 benzyl acetate multiple interactions ISO RGD:730900 6480464 benzyl acetate results in increased cleavage of and results in increased activity of PPP3CA protein CTD PMID:22952646 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:11134 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP3CA mRNA] CTD PMID:16377760 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of PPP3CA mRNA CTD PMID:15651846 bis(2-chloroethyl) sulfide decreases expression ISO RGD:11134 6480464 Mustard Gas results in decreased expression of PPP3CA mRNA CTD PMID:16377760 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPP3CA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:11134 6480464 bisphenol A results in decreased expression of PPP3CA mRNA CTD PMID:33221593 bisphenol A increases methylation ISO RGD:11134 6480464 bisphenol A results in increased methylation of PPP3CA promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:730900 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PPP3CA mRNA CTD PMID:28628672 cadmium dichloride increases expression ISO RGD:730900 6480464 Cadmium Chloride results in increased expression of PPP3CA mRNA CTD PMID:12160620 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of PPP3CA mRNA CTD PMID:31077537 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPP3CA mRNA CTD PMID:31077537 cadmium dichloride decreases expression ISO RGD:730900 6480464 Cadmium Chloride results in decreased expression of PPP3CA mRNA CTD PMID:18560533 calcitriol increases expression ISO RGD:730900 6480464 Calcitriol results in increased expression of PPP3CA mRNA CTD PMID:16002434 capsaicin multiple interactions EXP 6480464 PPP3CA protein affects the reaction [mustard oil inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]] CTD PMID:17590514 carbamazepine decreases expression EXP 6480464 Carbamazepine results in decreased expression of PPP3CA mRNA, Carbamazepine results in decreased expression of PPP3CA protein CTD PMID:14642444 carbon nanotube decreases expression ISO RGD:11134 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:730900 6480464 Nanotubes, Carbon results in increased expression of PPP3CA mRNA CTD PMID:32493873 chlordecone increases expression ISO RGD:11134 6480464 Chlordecone results in increased expression of PPP3CA mRNA CTD PMID:33711761 chlorendic acid multiple interactions ISO RGD:730900 6480464 chlorendic acid results in increased cleavage of and results in increased activity of PPP3CA protein CTD PMID:22952646 chlorpyrifos increases expression ISO RGD:11134 6480464 Chlorpyrifos results in increased expression of PPP3CA mRNA CTD PMID:20350560 cisplatin multiple interactions ISO RGD:730900 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA CTD PMID:21858171 clozapine multiple interactions EXP 6480464 [Clozapine binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein CTD PMID:16033416 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PPP3CA mRNA CTD PMID:12437575 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of PPP3CA mRNA, Clozapine results in decreased expression of PPP3CA protein CTD PMID:16033416 cocaine affects expression EXP 6480464 Cocaine affects the expression of PPP3CA mRNA CTD PMID:20187946 copper atom multiple interactions ISO RGD:730900 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PPP3CA mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:730900 6480464 [Chelating Agents binds to Copper] which results in decreased expression of PPP3CA mRNA CTD PMID:30911355 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of PPP3CA mRNA CTD PMID:26577399 cyclosporin A decreases activity ISO RGD:11134 6480464 Cyclosporine results in decreased activity of PPP3CA protein CTD PMID:19553475 , PMID:32220932 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PPP3CA protein CTD PMID:18344631 cypermethrin multiple interactions ISO RGD:730900 6480464 [cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin CTD PMID:10898953 dexamethasone multiple interactions ISO RGD:730900 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPP3CA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PPP3CA mRNA CTD PMID:28628672 diallyl disulfide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of PPP3CA mRNA CTD PMID:31077537 diarsenic trioxide increases expression ISO RGD:730900 6480464 Arsenic Trioxide results in increased expression of PPP3CA mRNA CTD PMID:17963750 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of PPP3CA mRNA CTD PMID:29223816 dimercaprol multiple interactions ISO RGD:11134 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP3CA mRNA] CTD PMID:16377760 diphenylmethane-4,4'-diisocyanate multiple interactions ISO RGD:11134 6480464 [[4 more ... CTD PMID:31609387 diphenylmethane-4,4'-diisocyanate increases expression ISO RGD:11134 6480464 4, 4'-diphenylmethane diisocyanate results in increased expression of PPP3CA mRNA CTD PMID:31609387 dorsomorphin multiple interactions ISO RGD:730900 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP3CA mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:730900 6480464 Doxorubicin results in decreased expression of PPP3CA mRNA CTD PMID:29803840 entinostat decreases expression ISO RGD:730900 6480464 entinostat results in decreased expression of PPP3CA mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:730900 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP3CA mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:11134 6480464 epoxiconazole results in decreased expression of PPP3CA mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:11134 6480464 ALDH2 protein inhibits the reaction [Ethanol results in increased expression of PPP3CA protein] CTD PMID:19332462 ethanol affects splicing ISO RGD:11134 6480464 Ethanol affects the splicing of PPP3CA mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PPP3CA mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:11134 6480464 Ethanol results in increased expression of PPP3CA protein CTD PMID:19332462 famotidine decreases expression EXP 6480464 Famotidine results in decreased expression of PPP3CA protein CTD PMID:30310171 fenofibrate multiple interactions ISO RGD:11134 6480464 PPARA protein affects the reaction [Fenofibrate results in decreased expression of PPP3CA mRNA] CTD PMID:21318169 fenofibrate decreases expression ISO RGD:11134 6480464 Fenofibrate results in decreased expression of PPP3CA mRNA CTD PMID:21318169 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of PPP3CA mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of PPP3CA mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:730900 6480464 Formaldehyde results in decreased expression of PPP3CA mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:730900 6480464 Fulvestrant inhibits the reaction [dan-shen root extract inhibits the reaction [IGF2 protein modified form results in increased expression of PPP3CA protein]] CTD PMID:32415908 furan increases expression EXP 6480464 furan results in increased expression of PPP3CA mRNA CTD PMID:20562052 gallic acid increases expression ISO RGD:730900 6480464 Gallic Acid results in increased expression of PPP3CA mRNA CTD PMID:34408198 gamma-tocopherol increases expression ISO RGD:11134 6480464 Tocopherols results in increased expression of PPP3CA mRNA CTD PMID:17654050 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PPP3CA mRNA CTD PMID:33387578 glyphosate decreases expression ISO RGD:730900 6480464 glyphosate results in decreased expression of PPP3CA mRNA CTD PMID:31295307 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of PPP3CA mRNA, Haloperidol results in decreased expression of PPP3CA protein CTD PMID:16033416 haloperidol multiple interactions EXP 6480464 [Haloperidol binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein CTD PMID:16033416 histamine increases expression EXP 6480464 Histamine results in increased expression of PPP3CA protein CTD PMID:30310171 hydrogen peroxide multiple interactions ISO RGD:11134 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO RGD:730900 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPP3CA mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PPP3CA mRNA CTD PMID:28628672 irinotecan decreases expression ISO RGD:730900 6480464 Irinotecan analog results in decreased expression of PPP3CA mRNA CTD PMID:18927307 irinotecan multiple interactions ISO RGD:730900 6480464 [Fluorouracil co-treated with Irinotecan] results in increased expression of PPP3CA mRNA, PPP3CA protein affects the susceptibility to [Fluorouracil co-treated with Irinotecan analog] CTD PMID:16391804 , PMID:18927307 ivermectin decreases expression ISO RGD:730900 6480464 Ivermectin results in decreased expression of PPP3CA protein CTD PMID:32959892 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PPP3CA protein CTD PMID:31714667 lipopolysaccharide multiple interactions EXP 6480464 Honghua extract, Carthamus tinctorius inhibits the reaction [Lipopolysaccharides results in increased expression of PPP3CA protein] CTD PMID:31714667 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of PPP3CA protein CTD PMID:15644446 methamphetamine multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of PPP3CA protein] CTD PMID:15644446 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of PPP3CA mRNA CTD PMID:30467583 methotrexate affects response to substance ISO RGD:730900 6480464 PPP3CA protein affects the susceptibility to Methotrexate CTD PMID:16217747 methylmercury chloride decreases expression ISO RGD:730900 6480464 methylmercuric chloride results in decreased expression of PPP3CA mRNA CTD PMID:28001369 metoprolol decreases expression EXP 6480464 Metoprolol results in decreased expression of PPP3CA protein CTD PMID:30310171 nitric oxide decreases expression ISO RGD:11134 6480464 Nitric Oxide deficiency results in decreased expression of PPP3CA mRNA CTD PMID:15878706 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP3CA mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:730900 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPP3CA mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO RGD:11134 6480464 Acetaminophen affects the expression of PPP3CA mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:11134 6480464 acetylleucyl-leucyl-norleucinal inhibits the reaction [Acetaminophen results in increased cleavage of PPP3CA protein] CTD PMID:35713544 paracetamol increases cleavage ISO RGD:11134 6480464 Acetaminophen results in increased cleavage of PPP3CA protein CTD PMID:35713544 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PPP3CA mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:730900 6480464 Acetaminophen results in increased expression of PPP3CA mRNA CTD PMID:21420995 , PMID:25704631 paraquat increases expression ISO RGD:730900 6480464 Paraquat results in increased expression of PPP3CA mRNA CTD PMID:28619522 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of PPP3CA mRNA CTD PMID:20136073 perindopril decreases expression EXP 6480464 Perindopril results in decreased expression of PPP3CA protein CTD PMID:18344631 phenobarbital decreases expression ISO RGD:11134 6480464 Phenobarbital results in decreased expression of PPP3CA mRNA CTD PMID:19363144 phenobarbital affects expression ISO RGD:11134 6480464 Phenobarbital affects the expression of PPP3CA mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:11134 6480464 pirinixic acid results in decreased expression of PPP3CA mRNA CTD PMID:21318169 pirinixic acid multiple interactions ISO RGD:11134 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of PPP3CA mRNA] CTD PMID:21318169 piroxicam multiple interactions ISO RGD:730900 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA CTD PMID:21858171 propiconazole decreases expression ISO RGD:11134 6480464 propiconazole results in decreased expression of PPP3CA mRNA CTD PMID:19363144 quercetin decreases expression ISO RGD:730900 6480464 Quercetin results in decreased expression of PPP3CA mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:730900 6480464 Quercetin results in decreased activity of [PPP3CA protein binds to PPP3R1 protein] CTD PMID:19880376 resveratrol multiple interactions ISO RGD:730900 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of PPP3CA mRNA CTD PMID:23557933 rimonabant multiple interactions ISO RGD:11134 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of PPP3CA mRNA] CTD PMID:19030233 risperidone multiple interactions EXP 6480464 [Risperidone binds to and results in decreased activity of DRD2 protein] which results in increased expression of PPP3CA protein CTD PMID:16033416 risperidone decreases expression EXP 6480464 Risperidone results in decreased expression of PPP3CA mRNA, Risperidone results in decreased expression of PPP3CA protein CTD PMID:16033416 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:11134 6480464 Buthionine Sulfoximine results in increased expression of PPP3CA mRNA CTD PMID:15878706 SB 431542 multiple interactions ISO RGD:730900 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP3CA mRNA CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of PPP3CA protein] CTD PMID:15644446 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of PPP3CA mRNA CTD PMID:32721576 sodium arsenite affects methylation ISO RGD:730900 6480464 sodium arsenite affects the methylation of PPP3CA gene CTD PMID:28589171 sodium fluoride decreases expression ISO RGD:11134 6480464 Sodium Fluoride results in decreased expression of PPP3CA mRNA CTD PMID:27862939 Soman decreases expression EXP 6480464 Soman results in decreased expression of PPP3CA mRNA CTD PMID:19281266 staurosporine decreases response to substance ISO RGD:11134 6480464 PPP3CA protein results in decreased susceptibility to Staurosporine CTD PMID:10679475 staurosporine increases cleavage ISO RGD:730900 6480464 Staurosporine results in increased cleavage of PPP3CA protein CTD PMID:10898953 tacrolimus hydrate multiple interactions ISO RGD:730900 6480464 [Tacrolimus results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin CTD PMID:10898953 tacrolimus hydrate decreases activity ISO RGD:11134 6480464 Tacrolimus results in decreased activity of PPP3CA protein CTD PMID:19553475 tert-butyl hydroperoxide decreases expression ISO RGD:730900 6480464 tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA CTD PMID:12419474 thapsigargin multiple interactions ISO RGD:730900 6480464 [cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin more ... CTD PMID:10898953 thapsigargin increases expression ISO RGD:730900 6480464 Thapsigargin results in increased expression of PPP3CA mRNA CTD PMID:17963750 thapsigargin increases cleavage ISO RGD:730900 6480464 Thapsigargin results in increased cleavage of PPP3CA protein CTD PMID:10898953 tocopherol increases expression ISO RGD:11134 6480464 Tocopherols results in increased expression of PPP3CA mRNA CTD PMID:17654050 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PPP3CA mRNA CTD PMID:25729387 trichloroethene multiple interactions ISO RGD:11134 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of PPP3CA mRNA] CTD PMID:15363585 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPP3CA mRNA CTD PMID:19448997 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PPP3CA mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:11134 6480464 troglitazone results in decreased expression of PPP3CA mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:11134 6480464 Tungsten results in decreased expression of PPP3CA mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:11134 6480464 Tunicamycin results in increased expression of PPP3CA mRNA CTD PMID:17127020 Tylophorine increases expression ISO RGD:730900 6480464 tylophorine analog results in increased expression of PPP3CA mRNA CTD PMID:19284764 valproic acid increases expression ISO RGD:730900 6480464 Valproic Acid results in increased expression of PPP3CA mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:730900 6480464 Valproic Acid affects the expression of PPP3CA mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:730900 6480464 Valproic Acid results in decreased methylation of PPP3CA gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PPP3CA mRNA CTD PMID:19015723 zoledronic acid increases expression ISO RGD:730900 6480464 zoledronic acid results in increased expression of PPP3CA mRNA CTD PMID:24714768